Encompass Health EHC
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
Key Insights
Encompass Health (EHC) Core Market Data and Business Metrics
Latest Closing Price
$102.08Price-Earnings Ratio
22.89Total Outstanding Shares
100.71 Million SharesDividend
$0.17 Per Share QuarterlySIC Description
Services-hospitalsPrimary Exchange
New York Stock ExchangeHeadquarters
9001 Liberty Parkway, Birmingham, AL, 35242
Historical Stock Splits
| Execution Date | Split Amount |
|---|---|
| No Historical Stock Splits | |
Short Interest
Track Short Interest Levels to Gauge Bearish Market Sentiment and Short Squeeze Potential
| Avg Daily Volume | Days to Cover | Settlement Date | Short Interest |
|---|---|---|---|
| 862,368 Shares | 2.41 | 3/14/2025 | 2,076,615 Shares |
| 655,007 Shares | 3.23 | 2/28/2025 | 2,114,345 Shares |
| 755,895 Shares | 2.34 | 2/14/2025 | 1,769,554 Shares |
| 636,223 Shares | 2.35 | 1/31/2025 | 1,492,326 Shares |
| 579,339 Shares | 3.19 | 1/15/2025 | 1,850,695 Shares |
| 632,426 Shares | 2.14 | 12/31/2024 | 1,353,327 Shares |
Cash Flow Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Net Cash Flow From Operating Activities, Discontinued | $-3.10 Million |
| Net Cash Flow, Discontinued | $-3.10 Million |
| Net Cash Flow From Operating Activities | $999.70 Million |
| Net Cash Flow From Investing Activities, Continuing | $-653.30 Million |
| Net Cash Flow From Financing Activities, Discontinued | $0 |
| Net Cash Flow From Investing Activities, Discontinued | $0 |
Income Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Income Tax Expense/Benefit | $150.20 Million |
| Net Income/Loss Attributable To Nonredeemable Noncontrolling Interest | $135.80 Million |
| Net Income/Loss Available To Common Stockholders, Basic | $452.90 Million |
| Net Income/Loss | $596.60 Million |
| Operating Income/Loss | $864.50 Million |
| Income/Loss Before Equity Method Investments | $746.60 Million |
Comprehensive Income
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Comprehensive Income/Loss Attributable To Parent | $455.70 Million |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $140.90 Million |
| Comprehensive Income/Loss | $596.60 Million |
| Other Comprehensive Income/Loss | $0 |
Balance Sheet
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Accounts Payable | $171 Million |
| Noncurrent Liabilities | $2.84 Billion |
| Prepaid Expenses | $42.30 Million |
| Other Current Assets | $245.80 Million |
| Current Liabilities | $841 Million |
| Liabilities And Equity | $6.53 Billion |
Historical Dividends
Current dividend: $0.17 Per Share Quarterly
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| Feb 20, 2025 | Apr 15, 2025 | Apr 1, 2025 | $0.17 | Quarterly |
| Oct 17, 2024 | Jan 15, 2025 | Jan 2, 2025 | $0.17 | Quarterly |
| Jul 24, 2024 | Oct 15, 2024 | Oct 1, 2024 | $0.17 | Quarterly |
| May 2, 2024 | Jul 15, 2024 | Jul 1, 2024 | $0.15 | Quarterly |
| Feb 28, 2024 | Apr 15, 2024 | Apr 1, 2024 | $0.15 | Quarterly |
| Oct 19, 2023 | Jan 16, 2024 | Jan 2, 2024 | $0.15 | Quarterly |